Article Versions Notes

Yang A, Lau ESH, Wu H, Ma RCW, Kong APS, So WY, Luk AOY, Fu AWC, Chan JCN, Chow E. Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1–4. Pharmaceuticals. 2022; 15(9):1140. https://doi.org/10.3390/ph15091140

Yang, Aimin, Eric S. H. Lau, Hongjiang Wu, Ronald C. W. Ma, Alice P. S. Kong, Wing Yee So, Andrea O. Y. Luk, Amy W. C. Fu, Juliana C. N. Chan, and Elaine Chow. 2022. "Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1–4" Pharmaceuticals 15, no. 9: 1140. https://doi.org/10.3390/ph15091140

Yang, A., Lau, E. S. H., Wu, H., Ma, R. C. W., Kong, A. P. S., So, W. Y., Luk, A. O. Y., Fu, A. W. C., Chan, J. C. N., & Chow, E. (2022). Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1–4. Pharmaceuticals, 15(9), 1140. https://doi.org/10.3390/ph15091140